Paper Review Records
All Paper Review Records
24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
22
days
Ecnoglutide: First Approvals
Authors
Matt ShirleyShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
312
days
The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir
Authors
Victor Abiola Adepoju; Abdulrakib Abdulrahim; Shankar BiswasShow moreShow less
Affiliations
1. Department of HIV and Infectious Diseases, Jhpiego Nigeria (An Affiliate of Johns Hopkins University), Abuja, Nigeria; 2. Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 3. Department of Internal Medicine, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, UkraineShow moreShow less
53
days
Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews
Authors
Giancarlo De la Torre Canales; Marie-Amélie Dureisseix; Thiago Germano dos Santos; Pedro Miguel Teixeira Carvas Cebola; Glauce Crivelaro do Nascimento; Tatiana Foscaldo; Rodrigo Lorenzi Poluha; Justin Durham; Nikolaos ChristidisShow moreShow less
Affiliations
1. Egas Moniz Interdisciplinary Research Centre (CiiEM), Egas Moniz School of Health and Sciences, Caparica, Portugal; 2. Newcastle Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK; 3. Department of Basic and Oral Biology, Faculty of Dentistry of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil; 4. Orofacial Pain Unit, CUF Tejo Hospital, Lisbon, Portugal; 5. Postgraduate Program in Temporomandibular Disorders and Orofacial Pain, Kikuchi Institute, Pará, Brazil; 6. Department of Dentistry, State University of Maringá, Paraná, Brazil; 7. School of Dental Sciences, Framlington Place Newcastle University, Newcastle-Upon-Tyne, UK; 8. Division of Oral Rehabilitation, Department of Dental Medicine, Karolinska Institutet, Huddinge, SwedenShow moreShow less
223
days
Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases
Authors
Bhupendra Raj Giri; Jamie Erin Spahn; Rawidh Alsaidalani; Beatriz Behrend-Keim; Mohammed Bhia; Jailen Haley Doyle; Matthew Joseph Herpin; Rex Corbin Moore; Nila Sangeetha Murali; Arifenur Safak; Hugh David Charles SmythShow moreShow less
Affiliations
1. Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, USA; 2. Austin, USA; 3. Department of Chemistry, The University of Texas at Austin, Austin, USAShow moreShow less
216
days
Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering
Authors
Sha Li; Ying Gao; Cheng-Gang Zhu; Jian-Jun LiShow moreShow less
Affiliations
1. Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaShow moreShow less
75
days
Chronic Ocular Surface Pain: A Missing Member of the Chronic Overlapping Pain Conditions?
Authors
Jonghoon Chang; Alex Hattenhauer; Luisa Saccaro; Ferida Mamatkazina; Elizabeth Felix; Lindsey De Lott; Anat GalorShow moreShow less
Affiliations
1. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, USA; 2. Surgical Services, Miami Veterans Affairs Medical Center, Miami, USA; 3. Bogomolets National Medical University, Kyiv, Ukraine; 4. Research Services, Miami Veterans Affairs Medical Center, Miami, USA; 5. Department of Physical Medicine and Rehabilitation, University of Miami Miller School of Medicine, Miami, USA; 6. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days